WHO WE ARE
WHAT WE DO
BOARD OF DIRECTORS
Fontacea was invited to participate in the "ICBC Cup · Shanghai Lingang Innovative Design and Entrep
Fontacea was invited to participate in the "ICBC Cup · Shanghai Lingang Innovative Design and Entrepreneurship Show" (hereinafter referred to as "Show")" that has recently completed its de...
Fontacea and Thousand Oaks reach strategic cooperation
April7, 2021,Nantong, Beijing——Fontacea (Shanghai) Pharmaceutical Co., Ltd announced strategicpartnership with Thousand Oaks Biopharmaceuticals（Nantong)Co., Ltd.Fontaceais a clinical stage biopharm...
Fontacea takes action in promoting the R&D and innovation of Chinese biomedicine
Bionnova was held in Shanghai fromDecember 9 to 10, 2020. The theme of this forum is "cutting edgetechnology and clinical progress of tumor immunotherapy, clinical R&Dstrategy and practice, acceler...
Fontacea supports Guzhang through alleviating poverty
It is the traditional virtue of the Chinese nation to help the needy and worship virtue.A group of local products from p...
"Innovate together to win the future" Fontacea successfully held the launch ceremony in Shenzhen
On April 9, 2021, the opening ceremony of Fontacea‘s entry into ShenzhenInternational Biological Valley · Life Science Industrial Park was grandlyheld. The company's leaders who attended the ceremo...
Mr Yanliang Chu, chairman of Fontacea, signed Dr David Brooks as business consultant in USA
Mr Yanliang Chu, chairman of Fontacea, signed Dr David Brooks as business consultant in USA starting from Feb 10th, 202...
NEWS & EVENTS
Better affordable medicines for patients in China and beyond.
Contact US ▶
©2020 - Shandong Fontacea Pharmaceutical Institute Co.,Ltd copyright.